۱۳۹۹ شنبه ۲۱ تير

 

 

Published papers from first round of cohort of:

“Kerman Coronary Artery Disease Risk Factors Study (KERCADRS)”

 

 

 

  1. Mohammadi TM, Sabouri A, Sabouri S, Najafipour H. Anxiety, depression, and oral health: A population-based study in Southeast of Iran. Dent Res J 2019;16:139-44.

 

  1. Gholamhossenian A, Shahouzehi B, Shokoohi M, Najafipour H. B12 and Folate Concentrations in Opium Addicts Compared to Healthy Subjects: A Case Control Study from Kerman Coronary Artery Disease Risk Study. Addict Health 2018; 10(3).

 

  1. Rezapour M, Shahesmaeili A, Hossinzadeh A, Zahedi R, Najafipour H, Gozashti MH. Comparison of lipid ratios to identify metabolic syndrome.Arch Iran Med. 2018;21(12):572–577.

 

 

  1. Najafipour H, Afshari M, Rostamzadeh F. Prevalence of Multiple Coronary Artery Disease Risk Factors in Kerman: A Population-Based Study in Southeast Iran. Iran J Med Sci. 2018 ;43(2):140-149.

 

 

  1. Mahmoodi M.R ,Najafipour H ,Mohsenpour M.A , Amiri M. The relationship between food insecurity with cardiovascular risk markers and metabolic syndrome components in patients with diabetes: A population‑based study from Kerman coronary artery disease risk study. Journal of Research in Medical Sciences 2017; 31(22):118

 

  1.  Mohammadi TM, Hasheminejad N, Salari HR, Rostamizadeh MR, Najafipour H. Association between tooth loss and opium addiction: Results of a community-based study on 5900 adult individuals in South East of Iran in 2015. J Int Soc Prevent Communit Dent 2017;7:186-90.

 

  1.  Saber A  , Naghibzadeh Tahami A ,Najafipour  H, Azmandian J. Assessment of Prevalence of Chronic Kidney Disease and Its Predisposing Factors in Kerman City. Nephrourol Mon 2017; 9(2):e41794.

 

  1. Mojgan Sanjari,  Zohreh Safi, Khatereh Mohammadi Tahroodi .HYPERTHYROIDISM AND HYPERPROLACTINEMIA: IS THERE ANY ASSOCIATION?. Endocrine Practice 2016;22(12):1377-1382

 

  1. Najafipour H, Moazenzadeh M, Afshari M,  Nasri HR, Khaksari M,  Forood A, Sheikzadeh K, Mirzazadeh A. Prevalence of  Low Physical Activity and its relationship with Other Cardiovascular Risk Factors: a Community-based Study (KERCADRS). Asian ARYA Atheroscler 2016;12(5):212-219.

 

 

  1. Najafipour H, Beik Ahmad. The Impact of Opium Consumption on Blood Glucose, Serum Lipids and Blood Pressure, and Related Mechanisms(A Review).Front Physiol 2016;7:436.

 

  1. Najafipour H, Shokohi M,Yousefzadeh G, SarvarAzimzadeh B, MoshtaghiKashanian G, Bagheri MM, Mirzazadeh A. Prevalence of dyslipidemia and its association with other coronary artery disease risk factors among urban population in Southeast of Iran: results of the Kerman coronary artery disease risk factors study (KERCADRS).J Diabetes& Metabolic disorders 2016;15:49.

 

 

  1. Najafipour H, Askaripour M, Hosseinzadeh A, Sadeghi Z. The Prevalence of Coronary Artery Diseases Risk Factors in Four Regions of Kerman City. JKUMS 2016;23(4):406-420. [Article in Persian]

 

  1. Najafipour H, Banivaheb G, Sabahi A, Naderi N,Nasirian M, Mirzazade A. Prevalence of anxiety and depression symptoms and their relationship with other coronary artery disease risk factors: A population-basedstudy on 5900 residents in Southeast Iran.Asian Journal of psychiatry 2016;20(2016):55–60.

 

 

  1. Foroozanfar Z, Ebrahimi H, Khanjani N, Bahrampour A, Najafipour H . Prevalence of Carpal Tunnel Syndrome in Diabetic Patients with and without Metabolic Syndrome.         J Endoc Diabetes Mellitus 2016;4(1).

 

  1. Yousefzadeh G, Gozashti MH, Najafipour H, GholamhosseinianNajar A, Bahramnejad A, Shokouhi M. Common autoimmune biomarkers, thyroid hormonal abnormalities, and beta cells dysfunction in patients with latent autoimmune diabetes in adults with type II diabetes mellitus. Diabetes&Metabolic Syndrome: Clinical Research&Reviews 10S (2016);S52–S55.

 

 

  1. Salimzadeh H, Najafipour H, Mirzaiepour F, Navadeh S, Shadkam-Farrokhi M, Mirzazadeh A. Prevalence of Active and Passive Smoking among Adult Population: Findings of a Population-Based Survey in Kerman,Iran (KERCADRS). Addict Health 2016;8(1).

 

  1. Najafipour H, Yousefzadeh Gh, Forood A, Karamouzian M, Shadkam M, Mirzazadeh A. Overweight and obesity prevalence and its predictors in a general population: A community-based study in Kerman, Iran (Kerman coronary artery diseases risk factors studies). ARYA Atheroscler 2016;12(1):18-27.

 

  1. Najafipour H, YeganehHajahmadi M, Nasri HR, Sadeghi Z. Effect of opium addiction and six other risk factors on hypertension: a population-based study in 5900 adults in Kerman. Iran JPP 2015;1(4):156-165.[in Persian].

 

 

  1. Masoomi M, Azdaki N, Shahouzehi B. Elevated Plasma Homocysteine Concentration in Opium-Addicted Individuals. Addict Health 2015;7(3-4).

 

  1. Safavi F, Yousefzadeh G, Shokoohi M, Safavi S, Najafipour H, ShadkamFarokhi M.Prevalence of Metabolic Syndrome in Patients with Periodontal Disease. Journal of Kerman University of Medical Sciences 2015;22(3):229-239.[in Persian].

 

 

  1. Najafipour H, Sabahi A, Mirrashidi F, Afshari M, Haghdoost AA. Sleep Status and its relationship with other Coronary Artery Diseases Risk Factors: Findings of a Community-based Study in South East of Iran. Journal of sleep disorders and therapy 2015;4(3):6 pages.

 

  1. Foroozanfar Z, Najafipour H, Khanjani N, Bahrampour A, Ebrahimi H. The prevalence of metabolic syndrome according to different criteria and its associated factors in type 2 diabetic patients in Kerman, Iran.Iran J Med Sciences 2015;40(6):522-525.

 

 

  1. Tajadini H, Divsalar K, Mehrabani M, Haghdoost A.A, Esmaeili Z, Shadkam M. The frequency of using herbal medicine among patients with hypertension in Kerman, Iran, 2012-2013. Journal of Evidence-Based Complementary and Alternative Medicine      2015; April, pages 1-4.

 

  1. Najafipour H, Masoomi M, Shahesmaeili A, Haghdoost AA, Afshari M, Nasri H Reza, Kahnooji M, Etemad K, Mirzazadeh A. Effect of opium consumption on coronary artery disease risk factors and oral health: Results of KERCADRS population-based survey on 5900 subjects aged 15-75 years. Int J Preventive Med 2015;6:42:7 pages.

 

 

  1. Yousefzadeh G, Shokoohi M, Najafipour H, Shadkamfarokhi M. Applying Framingham Risk Score for Prediction of Metabolic Syndrome: the Kerman Coronary Artery Disease Risk study (KERCADRS). ARYA Atherosclerosis 2015;11(3):1-7.

 

  1. Yousefzadeh G, Shokoohi M, Najafipour H, Eslami M, Salehi F. Association between opium use and metabolic syndrome in an urban population in southern Iran:  Results of the Kerman Coronary Artery Disease Risk factor Study (KERCADRS). Arya Atherosclerosis 2015,11(1):7 pages.

 

 

  1. Yousefzadeh G, Shokoohi M, Najafipour H. Inadequate control of diabetes and metabolic indices among diabetic patients: a population based study from the Kerman Coronary Artery Disease Risk Study (KERCADRS). International Journal of Health Policy and Management (IJHPM) 2015;4(5):271-277.

 

  1. Najafipour H, Sanjari M, Shokoohi M, Haghdoost AA, Afshari M, Shadkam M, Etemad K, Mirzazadeh A. Epidemiology of Diabetes Mellitus, Pre-Diabetes, Undiagnosed and Uncontrolled Diabetes and Its Predictors in General Population Aged 15 to 75 Years: A Community-based Study (KERCADRS) in Southeastern Iran. J Diabetes 2015 Sep;7(5):613-21.

 

 

  1. Gozashti MH, Shafiei M, EsmaeilianS, Najafipour H, MashroutehM. The prevalence of latent autoimmune diabetes in adults and its correlates in patients with type 2 diabetes in Kerman, Iran[2011]. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2015 Apr-Jun;9(2):104-7.

 

  1. Yousefzadeh Gh, SheiknAkhavan M. Age and gender differences in the clustering of metabolic syndrome combinations: a prospective cohort research from the Kerman Coronary Artery Disease Risk Study (KERCADRS). Diabetes&Metabolic Syndrome: Clinical Research & Reviews 2015;9(4):367-372.

 

 

  1. Aram-Ahmaddi M, Bahrampour A, Najafipour H. Predicting Type Two Diabetes and Determination of Effectiveness of Risk Factors Applying Logistic Regression Model. Journal of Kerman University of Medical Sciences 2014;21(2):103-113. [in Persian].

 

  1. Rahimi N, Gozashti M.H, Marefati H, Rahnama K, Aghaei I, Moosazadeh M. Prevalence of Cardiovascular Risk Factors in Diabetic Patients and its Relationship with Opium Consumption. Journal of Guilan University of medical Sciences 2014;22(88):49-57.[in Persian].

 

 

  1. Najafipour H, Nasri HR, Afshari M, Moazenzadeh M, Shokoohi M, Forood A, Koorosh E, Sadeghi B, Mirzazadeh A. Hypertension, Pre-Hypertension, Undiagnosed and Uncontrolled Hypertension and its Predictors in General Population Aged 15 to 75 Years: A Community-based Study in Southeastern Iran. International Journal of Public Health 2014;59(6):999-1009.

 

  1. Gozashti MH, Fedaei N, Shojaei M, Najafipour H. Determination of most suitable cut off point of waist circumference for diagnosis of metabolic syndrome in Kerman.Diabetes& Metabolic Syndrome:Clinical Research&Reviews 2014;8(1):8-12.

 

 

  1. Hayatbakhsh M, Zahedi MJ, Darvish-moghaddam S, Seyedmirzaie SM, Najafipour H, Haghdoust AA, Mahmoudi A.The Prevalence of Irritable Bowel Syndrome, and its Clinical Symptoms and Related Factorsamong the Adult Population of Kerman,Iran. Journal of Kerman University of Medical Sciences 2013;20(4):331-342.[in Persian]

 

  1. Yousefzadeh Gh, Mahdavi-Jafari F, Shokoohi M, Najafipour H, HaghdoostAA, ModaresNejad V.  Modulation of coronary artery disease risk factors by menopausal status: A population based study among Iranian women (KERCADRStudy). Arya Atherosclerosis 2013;9(6):332-336.

 

 

  1. RahimiN, Gozashti MH, Najafipour H, Shokoohi M, Marefati H. Potential Effect of Opium Consumption on Controlling Diabetes and Some Cardiovascular Risk Factors in Diabetic Patients. Addict Health 2013;5(3-4):1-6.

 

  1. Najafipour H, MalekMohammadi T, Foad Rahim, Haghdoost AA, ShadkamM,  Afshari M. Association of oral health as a cardiovascular disease risk factor (CVDRF) with other CVDRFs: Results from a community based study on 5900 adult subjects.ISRN Cardiology 2013June:1-6.

 

 

  1. Shahouzehi B, Shokouhi M, Najafipour H. The Effect of opium addiction on serum Levels of Adiponectinand Leptin in male subjects:a case control study from KERCADRS. EXCLI Journal 2013;12:916-923.

 

  1. Yousefzadeh Gh,Shokoohi M, Yeganeh M, Najafipour H.Role of gamma-glutamyl transferase (GGT) in diagnosis of impaired glucose tolerance and metabolic syndrome: A prospective cohort research from the Kerman Coronary Artery Disease Risk Study (KERCADRS). Diabetes & Metabolic Syndrome: Clinical Research & Reviews

       2012;6:(190–194).

 

  1. SamarehFekri M, Shokoohi M, Gozashti MH, Esmailian S, Jamshidian N, Shadkam-Farokhi M, Lashkarizadeh MR MalekpourAfshar R. Association between Anti-Thyroid Peroxidase Antibody and Asthma in Women.Iran J Allergy Asthma Immunol 2012;11(3): 241- 245.

 

  1. Foroozanfar Z, Ebrahimi H, Khanjani N, Bahrampour A, Najafipour H. Comparing indices of median nerve among diabetic patients with or without metabolic syndrome. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2017;11(S2):S669-S673.

 

  1. Najafipour H, Mirzazadeh A, HaghdoostAA, Shadkam M, Afshari M, et al.Coronary Artery Disease Risk Factors in an urban and pri-urban setting (KERCADR Study): Methodology and Preliminary Report. Iran J Public Health 2012;41(9):86-92.